Herbas VPB

Print
EN | LT
LT - BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF
EN - BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 403/14
C07D 401/14
A61K 31/4178
A61K 31/4025
A61P 31/12
C07D 405/14
European patent
(11) Number of the document 2880030
(13) Kind of document T
(96) European patent application number 13824843.0
Date of filing the European patent application 2013-08-05
(97) Date of publication of the European application 2015-06-10
(45) Date of publication and mention of the grant of the patent 2018-01-10
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/CN2013/000915
Date 2013-08-05
PCT application publication
(87) Number WO 2014/019344
Date 2014-02-06
Priority applications
(30) Number Date Country code
201210273491 2012-08-03 CN
201310116933 2013-04-03 CN
Inventors
(72)
ZHANG, Yingjun, CN
ZHANG, Jiancun, CN
XIE, Hongming, CN
REN, Qingyun, CN
TAN, Yumei, CN
LUO, Huichao, CN
Grantee
(73) Sunshine Lake Pharma Co., Ltd., No. 1, Gongye North Road Northern Industrial Area Songshan Lake, Dongguan, Guangdong 523000, CN
Title
(54) BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF
  BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF
Last update date 2021-04-30